INBRAIN Neuroelectronics cierra una ronda Series A de más de €14M liderada por Asabys Partners, Alta Life Sciences y CDTI para desarrollar terapias neuroelectrónicas inteligentes basadas en grafeno para trastornos cerebrales

By |2021-03-25T16:35:29+01:00March 26th, 2021|ALL, Portfolio News|

INBRAIN Neuroelectronics cierra una ronda Series A de más de €14M liderada por Asabys Partners, Alta Life Sciences y CDTI para desarrollar terapias neuroelectrónicas inteligentes basadas en grafeno para trastornos cerebrales [...]

INBRAIN Neuroelectronics raises over €14M Series A led by Asabys Partners, Alta Life Sciences and CDTI to develop intelligent graphene-based neuroelectronic therapies for brain related disorders

By |2021-03-25T16:36:28+01:00March 26th, 2021|ALL, Portfolio News|

INBRAIN Neuroelectronics raises over €14M Series A led by Asabys Partners, Alta Life Sciences and CDTI to develop intelligent graphene-based neuroelectronic therapies for brain related disorders [...]

Koa Health Closes Oversubscribed €30M Series A to Accelerate Growth Following Spinout From Telefónica

By |2021-02-09T16:20:16+01:00February 9th, 2021|ALL, Portfolio News|

Koa Health Closes Oversubscribed €30M Series A to Accelerate Growth Following Spinout From Telefónica   The digital mental healthcare provider will use funds to accelerate product development, expand [...]

Medlumics raises €14M in a Series E financing co-led by Asabys Partners, VI Partners and CDTI Innvierte, together with existing investors Andera Partners, Caixa Capital Risc and Innogest

By |2020-10-08T07:29:36+02:00October 8th, 2020|ALL, Portfolio News|

Medlumics raises €14M in a Series E financing co-led by Asabys Partners, VI Partners and CDTI Innvierte, together with existing investors Andera Partners, Caixa Capital Risc and Innogest   Medlumics [...]

Go to Top